|
Q3 2021
Filed on Nov 16, 2021
|
43,856
|
$102.73 - $108.01
$4.51M - $4.74M
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
6,070
|
$76.58 - $83.26
$465K - $505K
|
|
Mudrick Cap Acquisition Class A
|
Q3 2021
Filed on Nov 16, 2021
|
21,925
|
N/A
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
20,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
26,149
|
$1.36 - $2.25
$35.6K - $58.8K
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
5,665
|
$63.23 - $68.45
$358K - $388K
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
7,102
|
$73.77 - $83.61
$524K - $594K
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
18,910
|
$17.27 - $32.64
$327K - $617K
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
19,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
3,961
|
$78.25 - $86.49
$310K - $343K
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
8,810
|
$21.76 - $23.48
$192K - $207K
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
6,316
|
$83.59 - $91.68
$528K - $579K
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
5,428
|
N/A
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
372,133
|
$31.76 - $33.8
$11.8M - $12.6M
|
|
|
Q3 2021
Filed on Nov 16, 2021
|
2,775
|
$203.86 - $232.86
$566K - $646K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
20,000
|
$53.76 - $63.92
$1.08M - $1.28M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
22,547
|
$46.31 - $52.31
$1.04M - $1.18M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
2,069
|
$55.06 - $60.62
$114K - $125K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
8,106
|
$59.19 - $63.65
$480K - $516K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
25,850
|
$7.26 - $11.98
$188K - $310K
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
10,000
|
$33.34 - $35.42
$333K - $354K
|
|
Barclays Bk PLC I Path Ser B S&P 500 Vix Short Term Futures Etn
|
Q2 2021
Filed on Aug 16, 2021
|
14,000
|
N/A
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
51,800
|
$22.26 - $25.44
$1.15M - $1.32M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
19,110
|
$24.78 - $31.31
$474K - $598K
|
|
|
Q1 2021
Filed on May 13, 2021
|
810
|
$308.39 - $444.51
$250K - $360K
|
|
|
Q1 2021
Filed on May 13, 2021
|
22,410
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
956
|
$222.0 - $317.14
$212K - $303K
|
|
Gores Metropoulos Inc Com Cl A
|
Q4 2020
Filed on Feb 16, 2021
|
21,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,500
|
N/A
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
844
|
$49.2 - $61.12
$41.5K - $51.6K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
28
|
$55.23 - $62.39
$1.55K - $1.75K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
10
|
$245.73 - $284.63
$2.46K - $2.85K
|
|
Gw Pharmaceutic PLC F Sponsored Adr
|
Q3 2020
Filed on Nov 02, 2020
|
50
|
N/A
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
51
|
$190.17 - $209.73
$9.7K - $10.7K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
169
|
$43.67 - $53.89
$7.38K - $9.11K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
1,000
|
$22.2 - $30.89
$22.2K - $30.9K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
383
|
$30.04 - $32.09
$11.5K - $12.3K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
1,512
|
$264.77 - $305.71
$400K - $462K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
452
|
N/A
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
307
|
$91.75 - $105.0
$28.2K - $32.2K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
3,440
|
$34.67 - $43.16
$119K - $148K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
500
|
$28.84 - $33.76
$14.4K - $16.9K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
1,225
|
$50.98 - $68.4
$62.5K - $83.8K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
540
|
$104.49 - $118.88
$56.4K - $64.2K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
1,000
|
$18.41 - $23.82
$18.4K - $23.8K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
40
|
$107.44 - $122.24
$4.3K - $4.89K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
1,000
|
$19.03 - $21.94
$19K - $21.9K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
280
|
$18.5 - $24.56
$5.18K - $6.88K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
242
|
$33.61 - $40.81
$8.13K - $9.88K
|
|
|
Q3 2020
Filed on Nov 02, 2020
|
1,000
|
$29.42 - $37.95
$29.4K - $38K
|
|